SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 40 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,248,000 | +669.4% | 5,965,455 | +163.3% | 0.25% | +492.9% |
| Q4 2018 | $942,000 | -79.2% | 2,265,455 | 0.0% | 0.04% | -74.7% |
| Q3 2018 | $4,531,000 | -5.7% | 2,265,455 | 0.0% | 0.17% | -16.6% |
| Q2 2018 | $4,803,000 | -22.1% | 2,265,455 | 0.0% | 0.20% | -30.9% |
| Q1 2018 | $6,162,000 | -26.3% | 2,265,455 | 0.0% | 0.29% | -33.9% |
| Q4 2017 | $8,360,000 | +33340.0% | 2,265,455 | +17194.9% | 0.44% | +43500.0% |
| Q3 2017 | $25,000 | – | 13,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|